cjc ipamorelin dac CJC-1295 Blend 5MG Ipamorelin / CJC-1295 (With DAC):

Ipamorelin CERTIFICATES OF ANALYSIS 5 COAs BN-26IP02-001 Current Variant: Size: 2mg Ipamorelin 1.98 mg / 1.93 mg Purity 99.764% / 99.743% BN-25IP10-002 Current Variant: Size: 10mg Ipamorelin 10.38 mg Purity 99.95% BN-25IP05-003 Current Variant: Size: 5mg Ipamorelin 5.1 mg Purity 99.927% BN-25IP10-001 Previous Variant: Size: 10mg BN-25IP05-001 Previous Variant: Size: 5mg Formulation Ipamorelin is a single-peptide research formulation supplied for use in controlled laboratory and analytical environments

TB-500") under section S2.3, Growth Factors and Growth Factor Modulators, banned at all times, in and out of competition, for athletes subject to the WADA Code

Hydralazine lowers blood pressure & promotes an increase in cardiac output via afterload reduction Has antioxidant properties that help prevent the degradation of NO (Cole et al, 2011)

You must reconstitute the medication into a liquid using a regular needle and syringe, and then replace the needle before the subcutaneous injection

Once reconstituted, keep it refrigerated at 28C and use within the working shelf life described on the CoA

Ingredients & Identity CJC-1295 CAS: 863288-34-0 CJC-1295 MF/MW: C152H252N44O42 / 3367.93 g/mol Ipamorelin CAS: 170851-70-4 Ipamorelin MF/MW: C38H49N9O5 / 711.86 g/mol Mass per vial: 10 mg total combined lyophilizate Form: Lyophilized white powder Compound Lyophilized binary blend of CJC-1295 (Modified GRF 1-29, a 30-amino-acid GHRH analog) and Ipamorelin (synthetic pentapeptide)